AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Topical glucosamine/chondroitin cream relieves arthritic knee pain. (Small Study).
A topical cream containing glucosamine and chondroitin relieved pain in patients with osteoarthritis of the knee, said Marc M. Cohen and his colleagues at Monash University, Clayton, Australia.
Since oral glucosamine is subject to degradation by the liver, the researchers hypothesized that topical administration would have greater bioavailability.
In a randomized trial, 32 patients with knee osteoarthritis (OA) applied as needed the topical cream containing glucosamine sulfate 30 mg/g, chondroitin sulfate 50 mg/g, shark cartilage 140 mg/g, camphor, and peppermint oil.
Another 29 patients used a placebo cream that contained a small amount of peppermint oil to smell like the active cream.
After 4 weeks of therapy, visual analog scale pain scores in the test group decreased from 6.1 cm at baseline to 3.5 cm, while the placebo group scores decreased from 6.2 cm to 4.8 cm.
After 8 weeks, the visual analog pain scores had decreased to 2.8 ...
- Nabi Biopharmaceuticals Presents Data Showing Patients Treated with Altastaph...
- Press release article from: PR Newswire October 7, 2005 700+ words
...bloodstream infections) and fever versus the placebo group. As previously reported, the treated...Altastaph group versus 14 days in the placebo group). This substantial reduction in the...Altastaph group versus two days in the placebo group) and fever (two days in the Altastaph...
- Journal of Urology Article Reports MacroChem Drug Induced Erection in 67-75% of...
- Press release article from: PR Newswire August 26, 1999 700+ words
LEXINGTON, Mass., Aug. 26 /PRNewswire/ -- Investigators from Northwestern University Medical School have reported in the September 1999 Journal of Urology that Topiglan(TM), a topical drug under development by MacroChem Corporation (Nasdaq: MCHM), induced erection in 67 to 75 percent of impotent
- Novel agent eases acute heart failure symptoms: dyspnea was improved in 53% of...
- Magazine article from: Family Practice News Jancin, Bruce July 1, 2008 700+ words
CHICAGO -- It's full speed ahead for a pivotal phase III clinical trial of the novel drug rolofylline in patients with acute decompensated heart failure and renal dysfunction, on the basis of its impressive performance in a 301-patient pilot study. In the preliminary round, the selective adenosine
- Know facts, myths about treating osteoarthritis.(Knight Ridder Newspapers)
- Newspaper article from: Knight Ridder/Tribune News Service Harkness, Richard October 4, 2002 700+ words
...status, but there is no call for thyroid pills unless you have primary hypothyroidism. Be aware that the glucosamine and chondroitin cream you are using seem to be a marketing ploy designed to mislead people. There is no evidence that glucosamine or chondroitin...
- Increased Survival Results of Advanced Colorectal Cancer Patients in Phase I/II...
- Press release article from: Business Wire January 22, 1998 700+ words
...evaluable patients. The comparative placebo group was from a parallel study at the same...research organization in the UK. The placebo group from the CRC study had 77 evaluable...cancer. The treatment group and the placebo group had similar inclusion and exclusion...
- Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly...
- Press release article from: PR Newswire June 26, 2008 700+ words
...50mg group, and 78.2 minutes in the placebo group. On Nights 1 and 8 of treatment...001), and by 28.3 minutes in the placebo group. On Nights 22 and 29 of treatment...016), and by 33.9 minutes in the placebo group. All statistical comparisons are between...
- Nitric Oxide May Curb Neonatal Brain Damage.
- Magazine article from: OB GYN News JOHNSON, KATE June 1, 2000 700+ words
...or compromised blood flow. Babies in the placebo group were delivered by elective cesarean section...many low 5-minute Apgar scores in the placebo group; six babies in the placebo group scored less than 7, compared with only...
- VIVUS Announces New Data from Qnexa Diabetes Study.
- Press release article from: Business Wire June 26, 2008 700+ words
...baseline mean of 140.7 mm Hg in the placebo group (p=0.006). Similarly, diastolic...baseline mean of 86.3 mm Hg in the placebo group (p=0.015). Current standard...of 25.3 mg/dL or 8.7% in the placebo group (p=0.022). Fasting plasma glucose...
Source: HighBeam Research, Topical glucosamine/chondroitin cream relieves arthritic knee pain....